Academic Journal
Adding Ramucirumab To Second-Line Irinotecan, 5-Fluorouracil and Folinic Acid (Folfiri) Treatment for Metastatic Colorectal Carcinoma (Mcrc): Resource Utilization Data from Raise, A Global, Randomized, Double-Blind, Multicenter Phase 3 Study
العنوان: | Adding Ramucirumab To Second-Line Irinotecan, 5-Fluorouracil and Folinic Acid (Folfiri) Treatment for Metastatic Colorectal Carcinoma (Mcrc): Resource Utilization Data from Raise, A Global, Randomized, Double-Blind, Multicenter Phase 3 Study |
---|---|
المؤلفون: | Brück, P, Kisro, J, Cohn, AL, Yoshino, T, Van Cutsem, E, Hegewisch-Becker, S, Kullmann, F, Liepa, AM, Yang, L, Nasroulah, F, Tabernero, J |
المصدر: | Value in Health ; volume 20, issue 9, page A871 ; ISSN 1098-3015 |
بيانات النشر: | Elsevier BV |
سنة النشر: | 2017 |
المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1016/j.jval.2017.08.2552 |
الاتاحة: | http://dx.doi.org/10.1016/j.jval.2017.08.2552 https://api.elsevier.com/content/article/PII:S1098301517328863?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S1098301517328863?httpAccept=text/plain |
Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
رقم الانضمام: | edsbas.68678FD6 |
قاعدة البيانات: | BASE |
DOI: | 10.1016/j.jval.2017.08.2552 |
---|